Contact us at 914-666-4665

Dr. Daniel Cameron

Board-certified physician with 38+ years specializing in Lyme disease and tick-borne illnesses. Past President of ILADS (International Lyme and Associated Diseases Society) and first author of ILADS treatment guidelines. Dr. Cameron operates a solo practice focused on patient advocacy and evidence-based Lyme disease treatment. He is the author of 1,100+ articles spanning diagnosis, treatment, co-infections, and recovery from tick-borne illnesses. His work challenges conventional approaches that often leave patients undiagnosed or undertreated, emphasizing clinical judgment over rigid adherence to testing criteria that frequently produce false negatives.

Dr. Daniel Cameron

Congratulations Congressman Chris Gibson, NY 19th CD, on passage of the Lyme disease bill

Congratulations are also in order for Congressman Chris Smith, NJ for all his years of support and work on making this bill. Congressman Sean Maloney, NY and Wolf, VA are to be thanked for their leadership as well.  Steve Bulger, District Director, Congressman Chris, Gibson – NY 19th CD, 518-610-8133 (office) Thanks are also in order […]

Congratulations Congressman Chris Gibson, NY 19th CD, on passage of the Lyme disease bill Read More »

Lyme disease patients may struggle with depression

One study found that more than 1/3 of patients with chronic neurologic Lyme disease suffered from depression, in addition to fatigue, headaches, poor concentration, lightheadedness, and joint pain. While depression is not uncommon in patients with chronic illness, it does seem to be more prevalent among patients with Lyme disease, according to Dr. Robert Bransfield,

Lyme disease patients may struggle with depression Read More »

Borrelia miyamotoi FDA test

LabCorp Western Blot Policy: What Changed and Why It Matters

When LabCorp Restricted Western Blot Access In 2014, LabCorp announced a policy change that sent shockwaves through the Lyme disease community: physicians would no longer be able to order Western blot testing for Lyme disease unless the initial screening test (ELISA or IFA) was positive or equivocal. This meant that if a patient’s screening test

LabCorp Western Blot Policy: What Changed and Why It Matters Read More »

Doxycycline Shortage and Lyme Disease: Lessons From the Hudson Valley

Senator Schumer Addresses Doxycycline Shortage During Peak Lyme Season Senator Schumer addressed the growing shortage of doxycycline during an August 12, 2004 press conference in the Hudson Valley, New York. At the time, Lyme disease cases were rising sharply across the region, raising concern about access to one of the most commonly prescribed antibiotics for

Doxycycline Shortage and Lyme Disease: Lessons From the Hudson Valley Read More »

Back to School: The ABCs of Lyme and Tick-borne Infections | ILADS

For Immediate Release For Information or Interview Requests Contact: Sue Ferrara, PhD Email: pr*******@***ds.org Phone: (609) 947-9489 Back to School: The ABCs of Lyme and Other Tick-borne Infections As families transition from summer activities to back-to-school preparations, the International Lyme and Associated Diseases Society (ILADS) urges parents to think about where their children have spent

Back to School: The ABCs of Lyme and Tick-borne Infections | ILADS Read More »

Why ILADS 2014 treatment guidelines are important

The ILADS 2014 treatment guidelines for Lyme disease identified a number of key issues in making these recommendations: Lyme disease is a complex illness and patients may experience both acute and persistent manifestations Persistent manifestations may produce profound quality-of-life impairments, yet the mechanisms that produce persistent manifestations are poorly understood. The available evidence regarding the

Why ILADS 2014 treatment guidelines are important Read More »

Babesia in Dutchess County: Now the #2 Tick-Borne Illness

Babesia in Dutchess County, New York is now the second most common tick-borne illness behind Lyme disease. A co-infection of Babesia with Lyme disease can increase the severity and duration of illness — and the risk is higher than expected. Over 6% of questing nymphal ticks in Dutchess County were infected with the pathogens that

Babesia in Dutchess County: Now the #2 Tick-Borne Illness Read More »

Borrelia miyamotoi DNA test

Borrelia Miyamotoi DNA Test: New Sequencing Method

A Novel Diagnostic Approach for Dual Detection A new DNA sequence test for Borrelia miyamotoi and Borrelia burgdorferi offers hope for improved diagnosis. Krause et al. reported that B. miyamotoi can cause illness and is treatable. Yet, Krause et al also reported that traditional tests for Borrelia burgdorferi (Bb) cannot be used to diagnose B.

Borrelia Miyamotoi DNA Test: New Sequencing Method Read More »